Navigation Links
Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication
Date:7/22/2014

Lawrence, KS (PRWEB) July 22, 2014

Biofeedback – When a behavioral problem such as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication to best treat it can become a matter of trial and error. Analyzing brain patterns by using electroencephalography (EEG) can help predict which medicine will offer the best result and thus lower the risk of adverse drug events.

The article “Medication Prediction with Electroencephalography Phenotypes and Biomarkers” in the current issue of the journal Biofeedback offers evidence that quantitative EEG assessment can refine the selection of medications by detecting brain patterns. Author Jay Gunkelman uses the example of a 7-year-old child diagnosed with ADHD.

Following current clinical standards, a patient would be diagnosed with ADHD based on behavioral observations as described in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Although this approach defines a problem, it does not predict effective therapy.

Typically, the next step would be to determine which medication would successfully treat the behavior. For ADHD, the options include stimulants, anticonvulsants, antidepressants, and channel blockers—a diverse range of pharmaceutical choices for a single diagnostic cluster. Trying one drug, then another, brings the risk of adverse drug events or severe side effects for the child being treated for ADHD.

The author proposes that quantitative EEG patterns can provide a more reliable basis for medication selection than diagnostic category. Individuals with the same symptom-based diagnoses can show differing patterns of brain dysfunction. Using these neurophysiological indicators can lead to a more accurate selection of treatment and eliminate the trial-and-error approach.

This application of quantitative EEG is an evidence-based approach to medicine. This article summarizes the EEG’s neurophysiological indicators for the medication classes indicated for ADHD, based on the author’s 43 years of experience in the field and outcomes from psychiatric practices.

Although the fields of pharmacology and EEG intersected about 50 years ago, the use of EEG is currently outside clinical practice standards in psychiatry. Change is coming, however, as the DSM-V approach is being abandoned in favor of predictors of treatment efficacy.

Full text of the article, “Medication Prediction with Electroencephalography Phenotypes and Biomarkers,” Biofeedback, Vol. 42, No. 2, 2014, is available at http://www.aapb-biofeedback.com/doi/full/10.5298/1081-5937-42.2.03.

###

About Biofeedback
Biofeedback is published four times per year and distributed by the Association for Applied Psychophysiology and Biofeedback. AAPB’s mission is to advance the development, dissemination, and utilization of knowledge about applied psychophysiology and biofeedback to improve health and the quality of life through research, education, and practice. For more information about the association, see http://www.aapb.org.

Read the full story at http://www.prweb.com/releases/EGG/medication/prweb12026852.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
2. Lab Expertise Tapped to Understand How the Brain Retrieves Memories
3. Studies Show Pterostilbene Shows Promise for Anti-Aging and Maintaining Healthy Brain
4. Greathouse Books Released: Doc, I Want My Brain Back - My HBOT Miracle and Offers 22% to Help Stop the 22 Veteran Suicides Occurring Every Day
5. Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer
6. Cynde Margritz Finds Hope After Brain Injury With Neurofeedback
7. SRI International Scientists Discover Brain Circuit Activated during Sleep
8. Neural prosthesis restores behavior after brain injury
9. National Brain Tumor Society Announces the Defeat GBM Research Collaborative’s Project Plans and Investigator Teams
10. BHR Pharma Engages Particle Sciences to Develop Nasal Progesterone for Traumatic Brain Injury
11. Chaotic physics in ferroelectrics hints at brain-like computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In addition ... Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... VIC Technology ... joining the company’s board of directors. This addition continues to strengthen and diversify ... Calvin Goforth, CEO and Chairman. “He is a highly accomplished business executive with a ...
(Date:7/20/2017)... 20, 2017   KCNQ2 Cure Alliance  and ... company, today announced that they have completed the ... mutation implicated in KCNQ2 epileptic encephalopathy. They also ... second case involving an additional KCNQ2 genetic mutation. ... and Pairnomix entered into a collaboration to further ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):